atorvastatin has been researched along with Leukemia, Myeloid, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abuhantash, M; Arkill, KP; Ashworth, JC; Curd, J; Grundy, M; James, JR; Merry, CLR; Seedhouse, CH; Thompson, A; Wright, AJ | 1 |
| Bae, HJ; Cho, EJ; Choi, JY; Han, KR; Hong, BK; Hong, SP; Hyon, MS; Jin, HY; Jung, HW; Kim, CY; Kim, KS; Kim, SY; Kim, U; Lee, JB; Lee, KH; Lee, KJ; Lee, SR; Lee, SY; Nam, CW; Park, CG; Park, SJ; Park, TH; Rhee, MY; Ryu, JK; Seol, SH; Shin, JH; Yang, DH; Yu, GW | 1 |
1 trial(s) available for atorvastatin and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Randomized, multicenter, parallel, open, phase 4 study to compare the efficacy and safety of rosuvastatin/amlodipine polypill versus atorvastatin/amlodipine polypill in hypertension patient with dyslipidemia.
Topics: Amlodipine; Atorvastatin; Cholesterol, LDL; Double-Blind Method; Dyslipidemias; Humans; Hypertension; Leukemia, Myeloid, Acute; Rosuvastatin Calcium; Treatment Outcome | 2023 |
1 other study(ies) available for atorvastatin and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Hydrogel-Based Pre-Clinical Evaluation of Repurposed FDA-Approved Drugs for AML.
Topics: Atorvastatin; Bone Marrow; Humans; Hydrogels; Leukemia, Myeloid, Acute; Peptides | 2023 |